Renal Impairment Has No Relevant Effect on Long-Term Exposure of Linagliptin in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Friedrich, Christian
Emser, Angela
Woerle, Hans J.
Graefe-Mody, Ulrike
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1105-P
引用
收藏
页码：A303 / A304
页数：2
相关论文
共 50 条
  • [1] Renal Impairment Has No Clinically Relevant Effect on the Long-Term Exposure of Linagliptin in Patients With Type 2 Diabetes
    Friedrich, Christian
    Emser, Angela
    Woerle, Hans-Juergen
    Graefe-Mody, Ulrike
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (06) : 618 - 621
  • [2] Effectiveness and long-term safety of linagliptin in patients with type 2 diabetes and severe renal impairment
    Patel, S.
    Weber, S.
    Emser, A.
    von Eynatten, M.
    Woerle, H. -J.
    Gibelin, B.
    Katsadze, V.
    DIABETES & METABOLISM, 2012, 38 : A103 - A103
  • [3] Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment
    Newman, J.
    McGill, J. B.
    Patel, S.
    Friedrich, C.
    Sauce, C.
    Woerle, H. -J.
    DIABETOLOGIA, 2011, 54 : S333 - S333
  • [4] Long-term Efficacy and Safety of Linagliptin in Type 2 Diabetes Patients with Moderate to Severe Renal Disease
    Groop, Per-Henrik
    Perkovic, Vlado
    Cooper, Mark
    Crowe, Susanne
    Lee, Jisoo
    Patel, Sanjay
    Von Eynatten, Maximilian
    DIABETES, 2014, 63 : A264 - A264
  • [5] Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes
    Araki, E.
    Kawamori, R.
    Inagaki, N.
    Watada, H.
    Hayashi, N.
    Horie, Y.
    Sarashina, A.
    Thiemann, S.
    von Eynatten, M.
    Dugi, K.
    Woerle, H. -J.
    DIABETES OBESITY & METABOLISM, 2013, 15 (04): : 364 - 371
  • [6] Linagliptin versus glimepiride add-on for the long-term treatment of Type 2 diabetes mellitus
    Chilton, Robert
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (04) : 345 - 349
  • [7] Diabetes: Long-term metformin exposure linked with peripheral neuropathy in patients with type 2 diabetes mellitus
    Osório J.
    Nature Reviews Endocrinology, 2010, 6 (3) : 121 - 121
  • [8] Safety and Efficacy of Linagliptin in Type 2 Diabetes Patients with Severe Renal Impairment
    Sloan, Lance
    Newman, Jennifer
    Sauce, Christophe
    Von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans J.
    DIABETES, 2011, 60 : A114 - A114
  • [9] The safety and efficacy of Linagliptin in patients with type 2 diabetes with severe renal impairment
    Sloan, L.
    Newman, J.
    Sauce, C.
    von Eynatten, M.
    Patel, S.
    Woerle, H. J.
    Katsadze, V.
    DIABETES & METABOLISM, 2012, 38 : A102 - A103
  • [10] Effects of Long-term Treatment of Linagliptin on Glycemic Control in Japanese Patients with Type 2 Diabetes
    Kusunoki, Masataka
    Natsume, Yukie
    Tsutsui, Hideyo
    Miyata, Tetsuro
    Tsutsumi, Kazuhiko
    Oshida, Yoshiharu
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (08) : 1153 - 1159
12345